The Sri Lankan government has said in a statement that China has not submitted documents related to the third phase trial. In such a situation, now the order of vaccination of AstraZeneca has been ordered for the second phase of vaccination.
Colombo: Sri Lanka has decided to ban the use of the Chinese vaccine in the corona vaccination. The Chinese vaccine will not be used in the second phase of vaccination campaign in Sri Lanka, a government spokesperson indicated on Tuesday. Sri Lanka will now use the Oxford AstraZeneca vaccine instead. It has ordered 13.5 million doses of the Oxford-AstraZeneca vaccine. Earlier India had given five lakh doses of Oxford-AstraZeneca vaccine to Sri Lanka as a gift.
Government spokesperson Ramesh Pathirana said that only AstraZeneca vaccine is likely to be used for the second phase of vaccination in Sri Lanka as Chinese and Russian vaccines are not ready yet. He said that China has not yet submitted papers related to the third phase trial.
The Sri Lankan government had ordered 10 million doses of Serum Institute of India for the first phase of vaccination, costing $ 52.5 million. At the same time, the order of 3.5 million doses has been given directly to the AstraZeneca Institute in the UK. The spokesman of this government also gave information about this.
Significantly, before this, India had given five lakh doses of the vaccine as a gift to Sri Lanka. With this dose, the vaccination campaign started in Sri Lanka last January. India’s move was praised by Sri Lankan President Gotabaya Rajapaksa. The Sri Lankan government spokesman said that when the doses of other vaccines are given in the country, the government will work according to the best medical consultation.
Last month, India announced that it would send Kovid-19 vaccines to Sri Lanka and seven other countries – Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles, Afghanistan and Mauritius, under grant-in-aid. India has emerged as the most productive in the field of vaccine production and many countries have approached India to purchase the vaccine.
Nidhi Malviya is fun loving girl. She writes at NoobFeeds about various topics related to Finance, Technology, Business etc.